NDC properties for "Pradaxa 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule" (RxCUI 1723478)
About this data
The tables show NDC propoerties for Pradaxa 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule with the RxCUI 1723478
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Pradaxa 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule (RxCUI 1723478)
| MMSL_CODE | BD23544 |
|---|---|
| RxCUI | 1723478 |
| SPL_SET_ID | ba74e3cd-b06f-4145-b284-5fd6b84ff3c9 |
| Prescribable Synonym | Pradaxa 110 MG Oral Capsule |
| RXNAV_STR | Pradaxa 110 MG Oral Capsule |
| RxNorm Name | dabigatran etexilate 110 MG Oral Capsule [Pradaxa] |
| RxNorm Synonym | Pradaxa 110 MG (as dabigatran etexilate mesylate 126.83 MG) Oral Capsule |
| RxNorm Synonym | Pradaxa 110 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 1723478) |
NDC Properties
NDC Item 00597010854
| NDC 9 | 0597-0108 |
|---|---|
| NDC 10 | 0597-0108-54 |
| NDC Item | 00597010854 |
| Packaging | 1 BOTTLE in 1 CARTON (0597-0108-54) / 60 CAPSULE in 1 BOTTLE |
| COLORTEXT | BLUE(Blue) |
| Color | C48333 __ |
| FDA SPL set id | 750257 |
| Imprint code | R110 |
| Labeler | Boehringer Ingelheim Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2015-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA022512 |
| Score | 1 |
| Shape | C48336 |
| Size | 20 mm |
| Related queries | Properties for NDC 9 0597-0108 |
NDC Item 00597010860
| NDC 9 | 0597-0108 |
|---|---|
| NDC 10 | 0597-0108-60 |
| NDC Item | 00597010860 |
| Packaging | 10 BLISTER PACK in 1 CARTON (0597-0108-60) / 6 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | BLUE(Blue) |
| Color | C48333 __ |
| FDA SPL set id | 750257 |
| Imprint code | R110 |
| Labeler | Boehringer Ingelheim Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2015-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA022512 |
| Score | 1 |
| Shape | C48336 |
| Size | 20 mm |
| Related queries | Properties for NDC 9 0597-0108 |
NDC Item 00597010854
| NDC 9 | 0597-0108 |
|---|---|
| NDC 10 | 0597-0108-54 |
| NDC Item | 00597010854 |
| Packaging | 1 BOTTLE in 1 CARTON (0597-0108-54) / 60 CAPSULE in 1 BOTTLE |
| COLORTEXT | BLUE(Blue) |
| Color | C48333 __ |
| FDA SPL set id | 750257 |
| Imprint code | R110 |
| Labeler | Boehringer Ingelheim Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2015-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA022512 |
| Score | 1 |
| Shape | C48336 |
| Size | 20 mm |
| Related queries | Properties for NDC 9 0597-0108 |
NDC Item 00597010860
| NDC 9 | 0597-0108 |
|---|---|
| NDC 10 | 0597-0108-60 |
| NDC Item | 00597010860 |
| Packaging | 10 BLISTER PACK in 1 CARTON (0597-0108-60) / 6 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | BLUE(Blue) |
| Color | C48333 __ |
| FDA SPL set id | 750257 |
| Imprint code | R110 |
| Labeler | Boehringer Ingelheim Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2015-11-23 |
| Marketing status | ACTIVE |
| NDA | NDA022512 |
| Score | 1 |
| Shape | C48336 |
| Size | 20 mm |
| Related queries | Properties for NDC 9 0597-0108 |